Cheddar is partnering with StackCommerce to bring you the Cheddar Shop. This article doesn’t constitute editorial endorsement, and we earn a portion of all sales. 

Looking for a new job opportunity? Odds are, you’ve spent hours upon hours pouring over your résumé, tormented over the right bullet points to include and the correct verbiage to use. You’ve likely also taken a stab (or 1000) at writing your cover letter, which can feel like a job in itself. Applying for work is a notoriously tough task, especially when you consider that a whopping 75% of résumés go unseen by employers. 

Don’t be part of this sad statistic. With Rezi Résumé Software: Pro Lifetime Subscription, you can get AI-powered help creating optimized and compelling write-ups of your work experience. The smart résumé generator guides you every step of the way, making for an efficient and way less expensive process than if you hired help. 

Here’s how it works. Rezi uses AI to extract keywords from job descriptions, then writes an optimized résumé for you based on those words. It creates Applicant Tracking Software (ATS)-friendly content in flexible formats suitable for every experience level. If you’re curious how your existing résumé shapes up, you can also get instant feedback using the Rezi Score feature. 

With this course bundle, you’ll unlock access to unlimited resumes and cover letters that you can download in both PDF and DOCX formats. You’ll also reap the benefits of user-favorite features, like managing multiple CVs for different industries and catching those attention-grabbing keywords you may have missed otherwise. 

Over 100,000 job seekers have trusted Rezi with their résumés, and some have been tapped for interviews by Airbnb, Google, Microsoft, and Spotify, to name a few. Rezi’s 2020 survey found users had a 26.9% interview success rate. 

Try Rezi today and start getting more interviews and job offers faster. Get the Rezi Résumé Software: Pro Lifetime Subscription for $29 (Reg. $540).

Prices subject to change. 

Share:
More In Technology
New York Auto Show Puts Big Focus on Electric Vehicles
Lisa Whalen, Automotive and Mobility Analyst at Morning Consult, joined Cheddar News' Closing Bell to break down the famed auto show's emphasis on electric vehicles this year, reflecting a shift toward electrification in the automotive industry.
What Spending 665 Days in Space Feels Like
Peggy Whitson, Director of Human Space Flight, Axiom Space, joins Cheddar Innovates to discuss Axiom's involvement in the first fully-private mission to the ISS, and her experience spending 665 days in space.
Living in Outer Space; A New-Age Twist on Millenia-Old Remedies
On this episode of Cheddar Innovates, Peggy Whitson, Director of Human Space Flight, Axiom Space, breaks down Axiom's involvement in the first fully-private mission to the ISS, and her experience spending 665 days in space; William Li and Danielle Chang, co-founders of The Hao Life, discuss how they're shaking up the $71 billion supplement industry by putting a modern spin on traditional natural Chinese remedies; Cheddar gets a look at Curiosity Stream's 'Sagrada Familia: Gaudi's Challenge.'
Pillow Customization to Improve Sleep; Bringing Green Hydrogen to Scale
On this episode of Cheddar Innovates: President of The Pillow Bar breaks down how everyone can benefit from a pillow customized to their unique way of sleeping; CEO of H2Pro explains how to bring environmentally friendly hydrogen to scale; Cheddar gets a look at Curiosity Stream's 'Suppressed Science.'
Gardening to Improve Wellbeing; Future of A.I. in Healthcare
On this episode of Cheddar Innovates: Gardenuity CEO breaks down how gardening can improve your wellbeing; Augmedix CEO discusses how this technology is helping doctors fight burnout; Cheddar gets a look at Curiosity Stream's 'Suppressed Science.'
Innovation in Prosthetics; New Drug for Anti-Aging
On this episode of Cheddar Innovates: Atom Limbs CEO breaks down how the Atom Touch prosthetic is different from other prosthetics on the market; CEO & Chief Scientific Officer of MyMD explains how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases; A look at Curiosity Stream's 'The Future of Warfare.'
Load More